Can a phone app help pregnant women stick with addiction treatment?

NCT ID NCT06999811

Recruiting now Disease control Sponsor: Medical University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special therapy program with a mobile app helps pregnant people stay on their buprenorphine medication for opioid use disorder, compared to just logging their doses. About 37 pregnant women will be randomly assigned to either the app-based therapy or daily medication tracking. The goal is to see if the extra support improves treatment retention and engagement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (EMPWR) with mobile app
What this could lead to: If successful, this could show that a therapy app plus counseling helps pregnant people stick with their opioid treatment, improving health for mother and baby.
What could go wrong: This is a very small early feasibility study (37 people), so results may not apply widely. The therapy is extra work and may not improve retention over simple monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder opiate dependence Psychological Well-Being sleep-wake disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER PREGNANCY

Contacts and locations

Locations

Medical University of South Carolina
RECRUITING

Charleston, South Carolina, 29403, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.